ApoGen Biotechnologies, Inc. operates as a biotechnology company. The Company focuses on the development of a new class of therapeutics targeting drivers of cancer genomic mutation.

ApoGen Biotechnologies, Inc.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://apogenbiotech.com
Founded2014
Disease Focus
Development Stage
STOCK CODENon Listed
Address1616 Eastlake Avenue East, Suite 200, WA 98102SeattleUnited States
1616 Eastlake Avenue East, Suite 200, WA 98102
Seattle
United States
Contact Number+1 206-957-7300
+1 206-957-7300
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/apogen-biotechnologies-inc-” connections=”true” suffix=””]